Opposing action of estrogen receptors α and β on tumor necrosis factor-α gene expression and caspase-8-mediated apoptotic effects in HA22T cells

Molecular and Cellular Biochemistry

Volumn 287, Issue 1-2, 2006, Pages 137-145

  Huang, Erh Jung ^a,b   Wu, Cheng Chung ^c   Lee, Shin Da ^d   Chen, Juen Hau ^d   Liu, Jer Yuh ^d   Ko, Jiunn Liang ^d   Lin, James A ^e   Lu, Min Chi ^d   Chen, Li Mien ^f   Huang, Chih Yang ^d   Kuo, Wei Wen ^g  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b Department of Surgery   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptotic effects; Estrogen receptor ; HA22T cells; Tumor necrosis factor

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DNA FRAGMENT; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 8; CELL LINE, TUMOR; DNA FRAGMENTATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; HUMANS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745932254     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9092-4     Document Type: Article

References (42)

1. Pisani P, Parkin DM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999
2. Hall JM, Couse JF, Korach KS: The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872, 2001
3. Moggs JG, OrphOnides G: Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2: 775-781, 2001
4. Grasso P: Malnutrition, liver damage, and cancer. Nutr Cancer 3: 103-108, 1981
5. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P: Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature 320: 134-139, 1986
6. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82: 4258-4265, 1997
7. Giguere V, Tremblay A, Tremblay GB: Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids 63: 335-339, 1998
8. Saunders PT: Oestrogen receptor beta (ER beta). Rev Reprod 3: 164-171, 1998
9. Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK: Estrogen receptor-beta mRNA expression in rat ovary: Down-regulation by gonadotropins. Mol Endocrinol 11: 172-182, 1997
10. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997
11. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11: 353-365, 1997
12. Hayashi S, Yoshida T: Regulation of ER(estrogen receptor) gene expression in the genesis and development of breast cancer. Nippon Rinsho 58: 495-503, 2000
13. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA: Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9: 1-13, 2002
14. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC: Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428, 2004
15. Ito T, Tachibana M, Yamamoto S, Nakashima J, Murai M: Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer. Eur Urol 40: 557-563, 2001
16. Signoretti S, Loda M: Estrogen receptBr beta in prostate cancer: brake pedal or accelerator? Am J Pathol. 159: 13-16, 2001
17. Campbell-Thompson M, Lynch IJ, Bhardwaj B: Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61: 632-640, 2001
18. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG: Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39: 1251-1258, 2003
19. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95: 1505-1514, 1997
20. Delbes G, Levacher C, Pairault C, Racine C, Duquenne C, Krust A, Habert R: Estrogen receptor beta-mediated inhibition of male germ cell line development in mice by endogenous estrogens during perinatal life. Endocrinology 145: 3395-3403, 2004
21. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, Gustafsson JA: Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci U S A 101: 9375-9380, 2004
22. Nagasue N, Kohno H, Chang YC, Yamanoi A, Nakamura T, Yukaya H, Hayashi T: Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas. Ann Surg. 212: 150-154, 1990
23. Villa E, Camellini L, Dugani A, Zucchi F, Grottola A, Merighi A, Buttafoco P, Losi L, Manenti F: Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res 55: 498-500, 1995
24. Ren Z, Yang B, Ye S: Estrogen receptor expression and its relationship with biologic feature in hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 19: 10-13, 1997
25. Villa E, Colantoni A, Camma C, Grottola A, Buttafoco P, Gelmini R, Ferretti I, Manenti F: Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems. J Clin Oncol 21: 441-446, 2003
26. Falcioni R, Kennel SJ, Giacomini P, Zupi G, Sacchi A: Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res 46: 5772-5778, 1986
27. Lottich SC, Johnston WW, Szpak CA, Delong ER, Thor A, Schlom J: Tumor-associated antigen TAG-72: Correlation of expression in primary and metastatic breast carcinoma lesions. Breast Cancer Res Treat 6: 49-56, 1985
28. Moon WS, Chang K, Tarnawski AS: Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol 35: 424-429, 2004
29. Takemura H, Kwan CY, Ohshika H: Calcium antagonistic actions of tetrandrine depend on cell types. Res Commun Mol Pathol Pharmacol 90: 59-68, 1995
30. Li J, Zheng R, Wang Z: Mechanisms of the induction of apoptosis in human hepatoma cells by tumour necrosis factor-alpha. Cell Biol Int 25: 1213-1219, 2001
31. Shima Y, Nakao K, Nakashima T, Kawakami A, Nakata K, Hamasaki K, Kato Y, Eguchi K, Ishii N: Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells. Hepatology 30: 1215-1222, 1999
32. Hui R, Cornish AL, McClelland RA, Robertson JF, Blamey RW, Musgrove EA, Nicholson RI, Sutherland RL: Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res 2: 923-928, 1996
33. Lamb J, Ladha MH, McMahon C, Sutherland RL, Ewen ME: Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol Cell Biol 20: 8667-8675, 2000
34. Balasenthil S, Barnes CJ, Rayala SK, Kumar R: Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 567: 243-247, 2004
35. Vater CA, Bartle LM, Dionne CA, Littlewood TD, Goldmacher VS: Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts. Oncogene 13: 739-748, 1996
36. Kim HS, Ingermann AR, Tsubaki J, Twigg SM, Walker GE, Oh Y: Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res 64: 2229-2237, 2004
37. Bush JA, Cheung KJ, Jr, Li G: Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271: 305-314, 2001
38. NichKlson DW, Thornberry NA: Caspases: killer proteases. Trends Biochem Sci 22: 299-306, 1997
39. Li P, Nijhawan D, Wang X: Mitochondrial activation of apoptosis. Cell 116: S57-59, 52 p following S59, 2004
40. Ainbinder E, Revach M, Wolstein O, Moshonov S, Diamant N, Dikstein R: Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol 22: 6354-6362, 2002
41. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA: Estrogen rSceptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55: 163-193; discussion 194-165, 2000
42. Bezwoda WR, Meyer K: Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells. Cancer Res 50: 5387-5391, 1990